Comprehensive clinical analysis of gastric-type endocervical adenocarcinoma: a real-world multicenter study
G-EAC exhibits aggressive behavior and unfavorable prognosis, with a 5-year OS of 46.1%. Multimodal treatment, particularly surgery combined with chemotherapy, remains the cornerstone of management and may improve survival. Prospective multicenter studies are warranted to further define optimal therapeutic strategies for this rare entity.
Authors
- Lele Zang (ORCID: https://orcid.org/0000-0002-4151-3182)
- Yanhong Zhuo (ORCID: https://orcid.org/0009-0001-9331-6025)
- Cheng‐Zhi Jiang (ORCID: https://orcid.org/0009-0006-9340-5091)
- Huaiwu Lu (ORCID: https://orcid.org/0000-0002-7668-3333)
- Lele Chang (ORCID: https://orcid.org/0000-0002-1305-9058)
- Li Li (ORCID: https://orcid.org/0000-0001-9479-6908)
- Ling Lin (ORCID: https://orcid.org/0000-0003-0559-2319)
- Qin Xu (ORCID: https://orcid.org/0009-0004-5916-9828)
- Jing Liu (ORCID: https://orcid.org/0000-0001-5557-0084)
- Yaxin Kang (ORCID: https://orcid.org/0009-0009-7585-5250)
Institutions
- Fujian Medical University (CN)
- Harbin Medical University (CN)
- Sun Yat-sen University (CN)
- Sun Yat-sen Memorial Hospital (CN)
- Zhangzhou Municipal Hospital of Fujian Province (CN)
- Third Affiliated Hospital of Harbin Medical University (CN)
- Fujian Provincial Cancer Hospital (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-11-14
- DOI
- https://doi.org/10.1080/07853890.2025.2584735
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00